The Swedish public health authority had initially approved the vaccine for people over the age of 18, the website writes Euractive.
The authority announced this week that it is revoking its decision because the vaccine increases the risk of inflammation of the heart muscle and inflammation of the pericardium. However, the risk is low.
The vaccine is not widely used in Sweden, where around 7,000 doses have been administered so far.
Related posts:
Believers Prepare for Good Friday Procession Despite Jerusalem Tensions: Reuters
How was the substitution of imports in foods and what it introduced, 17 August 2022 | e1.ru
Egg Crisis in Russia: Lukashenko Mocks Russian Authorities during Eurasian Economic Council Meeting
India Achieves Historic Soft Landing on Moon's South Pole on Modest Budget
